
--- Page 1 ---
Page 1 of 2 UUID:98C704DE-0914-49F1-80F9-36CFE52B8484 Patient:  TCGA-B6-A402-01A-PR Redacted AP Surgical Pathology: Surg Path CLINICAL HISTORY: Palpable 8:00 mass, rule out malignancy. If invasive carcinoma, please obtain ER, PR, EGFR, HER2/Neu by immunohistochemistry; for all 2+ IHC results please do Fish analysis. GROSS EXAMINATION: A. "usncb right breast, three cores, 8:00 region", received in formalin is a 2.1 x 0.2 x 0.1 cm aggregate of fibrofatty needle core tissue fragments are submitted entirely in a mesh bag in block Al.. 1cD-o-3 carcinornq,inF1Hghing ductg1 N0S MICROSCOPIC EXAMINATION: 8so0J3 Microscopic examination is performed. DIAGNOSIS: A. "USNCB RIGHT BREAST, THREE CORES, 8:OO REGION" (ULTRASOUND GUIDED NEEDLE CORE BIOPSY) : INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3.S TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE:  3. IN-SITU CARCINOMA: NOT IDENTIFIED. VASCULAR INVASION: ABSENT. CALCIFICATION: PRESENT. ESTROGEN/PROGESTERONE RECEPTOR, HER2/NEU, AND EGFR ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: A1. RESULTS WILL BE ISSUED IN AN ADDENDUM. I certify that I personally conducted the diagnostic evaluation of the above specimen(s) and have rendered the above diagnosis(es).. Electronically signed:t ADDENDUM 1: Please see for results of supplementary tests. I certify that I personally conducted the diagnostic evaluation of the above specimen(s) and have rendered the above diagnosis(es).. Electronically signed: Performed by: Attending MD: Ordering MD: